As RB1 gene mutation in either germline or somatic cells is required to initiate RB development and other genomic changes have also been found in primary tumors, RB has been considered as a genetic disease and early studies have focused on identification of additional genetic lesions that might cooperate with the tumor‐initiating RB1 mutations to drive malignant progression of RB. Here, RB1 is linked to neoplasm.